Remove Bioinformatics Remove Laboratories Remove Pharma Companies
article thumbnail

Case study: Extracting tidy data from Open Targets Genetics with Otargen

The Open Targets Blog

Amir Feizi is the Director of Bioinformatics at OMass Therapeutics, a spinout from Professor Dame Carol Robinson’s Laboratory at the University of Oxford. Their work was recently published in Bioinformatics. Amir Feizi and Ray Kamalika What inspired you to create Otargen? Why did you decide to share this openly?

article thumbnail

Navigating the AI revolution: a roadmap for pharma’s future

Drug Target Review

Data generation for drug discovery extends beyond the internet, encompassing data from laboratory instruments, empathic increase in radiomic output, and real-world evidence (RWE) from clinical settings ( Figure 1 ). Techbio companies have initiated this approach.